FORA Stock Overview
Provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Forian Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.10 |
| 52 Week High | US$4.15 |
| 52 Week Low | US$1.98 |
| Beta | 1.09 |
| 11 Month Change | -0.47% |
| 3 Month Change | -12.50% |
| 1 Year Change | -14.63% |
| 33 Year Change | -77.07% |
| 5 Year Change | n/a |
| Change since IPO | -90.83% |
Recent News & Updates
Recent updates
The Consensus EPS Estimates For Forian Inc. (NASDAQ:FORA) Just Fell A Lot
Aug 18
Forian (NASDAQ:FORA) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 05Unpleasant Surprises Could Be In Store For Forian Inc.'s (NASDAQ:FORA) Shares
Apr 03Is Forian (NASDAQ:FORA) Using Too Much Debt?
Feb 27Investors Give Forian Inc. (NASDAQ:FORA) Shares A 28% Hiding
May 05Forian to become a part of Russell 3000® Index
Jun 07Shareholder Returns
| FORA | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 2.9% | -10.1% | -2.1% |
| 1Y | -14.6% | 5.6% | 29.7% |
Return vs Industry: FORA underperformed the US Healthcare Services industry which returned 6.6% over the past year.
Return vs Market: FORA underperformed the US Market which returned 29.6% over the past year.
Price Volatility
| FORA volatility | |
|---|---|
| FORA Average Weekly Movement | 3.6% |
| Healthcare Services Industry Average Movement | 8.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: FORA has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: FORA's weekly volatility has decreased from 10% to 4% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 37 | Max Wygod | forian.com |
Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company’s subscription and services-based solutions cover the life sciences, pharma services, and healthcare payer and provider industries.
Forian Inc. Fundamentals Summary
| FORA fundamental statistics | |
|---|---|
| Market cap | US$63.14m |
| Earnings (TTM) | -US$4.35m |
| Revenue (TTM) | US$19.71m |
3.3x
P/S Ratio-15.0x
P/E RatioIs FORA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FORA income statement (TTM) | |
|---|---|
| Revenue | US$19.71m |
| Cost of Revenue | US$6.50m |
| Gross Profit | US$13.21m |
| Other Expenses | US$17.56m |
| Earnings | -US$4.35m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 67.03% |
| Net Profit Margin | -22.08% |
| Debt/Equity Ratio | 90.6% |
How did FORA perform over the long term?
See historical performance and comparison